1. Home
  2. CNTN vs IGA Comparison

CNTN vs IGA Comparison

Compare CNTN & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.36

Market Cap

178.5M

Sector

Health Care

ML Signal

N/A

Logo Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

IGA

Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

BUY

Current Price

$9.86

Market Cap

162.0M

Sector

Finance

ML Signal

BUY

Company Overview

Basic Information
Metric
CNTN
IGA
Founded
2017
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
178.5M
162.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNTN
IGA
Price
$2.36
$9.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 694.2K
84.2K
Earning Date
11-11-2026
01-01-0001
Dividend Yield
N/A
★ 8.93%
EPS Growth
★ 88.10
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$9.21
52 Week High
$5.27
$10.77

Technical Indicators

Market Signals
Indicator
CNTN
IGA
Relative Strength Index (RSI) 52.97 29.07
Support Level $1.91 $9.85
Resistance Level $2.40 $9.93
Average True Range (ATR) 0.20 0.22
MACD -0.00 -0.08
Stochastic Oscillator 50.88 15.87

Price Performance

Historical Comparison
CNTN
IGA

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.

Share on Social Networks: